The store will not work correctly when cookies are disabled.
N-[4-(1H-Pyrrol-2-yl)-thiazol-2-yl]-guanidine: (maleate)
ID: ALA1744211
Max Phase: Preclinical
Molecular Formula: C12H13N5O4S
Molecular Weight: 207.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)Nc1nc(-c2ccc[nH]2)cs1.O=C(O)/C=C\C(=O)O
Standard InChI: InChI=1S/C8H9N5S.C4H4O4/c9-7(10)13-8-12-6(4-14-8)5-2-1-3-11-5;5-3(6)1-2-4(7)8/h1-4,11H,(H4,9,10,12,13);1-2H,(H,5,6)(H,7,8)/b;2-1-
Standard InChI Key: HADPSUQMPQOFPS-BTJKTKAUSA-N
Molfile:
RDKit 2D
22 22 0 0 0 0 0 0 0 0999 V2000
6.1668 -22.7394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6390 -22.0658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4163 -22.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3377 -22.7567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6563 -23.3958 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0841 -21.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5086 -22.7567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4336 -23.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3490 -21.0294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7463 -22.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1782 -21.0467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4200 -21.8354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0940 -22.0312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0826 -23.4649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8045 -18.0543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6295 -18.0543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3920 -18.7687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0420 -18.7687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8670 -18.7687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6295 -19.4832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5670 -18.7687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8045 -19.4832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 1 1 0
5 1 1 0
6 3 1 0
7 4 1 0
8 5 1 0
9 6 1 0
10 6 2 0
11 9 1 0
12 10 1 0
13 7 2 0
14 7 1 0
3 8 2 0
11 12 2 0
15 16 2 0
15 17 1 0
16 18 1 0
18 19 2 0
18 20 1 0
17 21 1 0
17 22 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 207.26 | Molecular Weight (Monoisotopic): 207.0579 | AlogP: 1.44 | #Rotatable Bonds: 2 |
Polar Surface Area: 90.58 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.71 | CX LogP: 1.32 | CX LogD: 0.85 |
Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.44 | Np Likeness Score: -1.67 |
References
1. LaMattina JL, McCarthy PA, Reiter LA, Holt WF, Yeh LA.. (1990) Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase., 33 (2): [PMID:2153817] [10.1021/jm00164a012] |